StreetAlpha
Generate Biomedicines, Inc. · SEC Form 4

GENB Insider Trading

From SEC Form 48 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Generate Biomedicines, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net buyers over the last 12 months: $150M bought and $201K sold.

← GENB stock page

Insiders are net buyers
Bought, 12 months$150M6 buys · 6 insiders
Sold, 12 months$201K2 sales · 1 insiders
Net+$150Mbought minus sold
Planned sales100%of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
DecJanFeb2026-03: bought $150MMarAprMayJunJulAug2026-09: sold $16KSep2026-10: sold $185KOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when GENB insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an GENB officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

GENB cluster buys

All GENB cluster buys →
  • 6 insiders bought $150MTrades Mar 2, 2026 to Mar 4, 2026 · public Mar 2, 2026

A cluster buy is two or more insiders buying on the open market within 30 days of each other.

Every GENB insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Oct 29, 2026Frances ArnoldDirectorSale plan11,409$16.19$185K220,063Nov 4Form 4
Sep 1, 2026Frances ArnoldDirectorSale plan1,000$16.00$16K231,472Sep 3Form 4
Mar 4, 2026Michael NallyCEOBuy20,000$12.00$240K572,707Mar 6Form 4
Mar 2, 2026Flagship Pioneering Fund VI, L.P.10% ownerBuy4,687,500$16.00$75M1,562,500Mar 2Form 4
Mar 2, 2026Jane L MendilloDirectorBuy1,500$16.00$24K1,500Mar 2Form 4
Mar 2, 2026Nutritional Health LTP Fund General Partner LLC10% ownerBuy4,687,500$16.00$75M1,562,500Mar 2Form 4
Mar 2, 2026Jason SilversPresident & CFOBuy2,000$16.00$32K1,000Mar 2Form 4
Mar 2, 2026Beth GrousChief People OfficerBuy300$16.00$5K300Mar 2Form 4

GENB insider trading FAQ

Are GENB insiders buying or selling?

Insiders are net buyers over the last 12 months. 6 insiders bought $150M of GENB on the open market in 6 trades, and 1 sold $201K in 2 trades, 100% of that under pre-arranged trading plans.

When did an GENB insider last buy shares?

Michael Nally (CEO) bought 20,000 shares for $240K on Mar 4, 2026, reported on Mar 6, 2026.

When did an GENB insider last sell shares?

Frances Arnold (Director) sold 11,409 shares for $185K on Oct 29, 2026, under a pre-arranged trading plan.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice